Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrainline Regulatory News (TRN)

Share Price Information for Trainline (TRN)

Share Price is delayed by 15 minutes
Get Live Data
214.00    -4.40 (-2.01%)
Bid:
214.20
Ask:
214.80
Spread: 0.60 (0.28%)
Market Cap: £755.88m
TRN Live PriceLast checked at - London Stock Exchange

Intraday Trainline Share Chart

Stabilisation Notice

21 Jun 2019 07:06

RNS Number : 0073D
Morgan Stanley & Co. Int'l plc
21 June 2019
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Trainline plc

Stabilisation Notice

21/06/19

Morgan Stanley & Co. International plc (contact: James Manson-Bahr; telephone: +44 20 7425-3672) hereby gives notice, as Stabilisation Manager, that the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014.

 

The securities:

Issuer:

Trainline plc

Securities:

Ordinary shares ("Shares") of the Issuer (ISIN: GB00BKDTK925)

Offer size:

271,655,470 ("Offer Shares") (excluding the over-allotment option)

Offer price:

350 pence

Stabilisation:

Stabilising Manager(s):

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA

Stabilisation period expected to start on:

Friday 21st June 2019

Stabilisation period expected to end no later than:

Friday 19th July 2019

Maximum size of over-allotment facility:

Up to 40,748,321 shares

Stabilisation trading venue:

London Stock Exchange

Over-allotment Option:

Terms:

KKR Victoria Aggregator L.P. has granted Morgan Stanley & Co. International plc, in its capacity as stabilisation manager, and for the account of the underwriters, the option to acquire up to an additional 40,748,321 Shares at the Offer Price (representing up 15 per cent of the Offer size).

Duration:

This option may be executed at any time during the stabilisation period.

 

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

END.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAFBMFTMBMTMJL
Date   Source Headline
27th May 20201:47 pmRNSHolding(s) in Company
26th May 20204:00 pmRNSDirector/PDMR Shareholding
20th May 20204:00 pmRNSNotice of AGM
14th May 20208:29 amRNSHolding(s) in Company
7th May 20208:44 amRNSHolding(s) in Company
7th May 20207:00 amRNSResults for the year ended 29 February 2020
1st May 202011:04 amRNSHolding(s) in Company
29th Apr 20207:00 amRNSCovenant waiver agreed with lenders
16th Apr 20203:57 pmRNSHolding(s) in Company
15th Apr 20203:44 pmRNSHolding(s) in Company
9th Apr 20204:14 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSUpdate in response to COVID-19
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:38 pmRNSPrice Monitoring Extension
12th Mar 20207:00 amRNSTrainline Full Year 2020 Trading Update
11th Mar 202012:54 pmRNSHolding(s) in Company
5th Mar 202010:00 amRNSHolding(s) in Company
26th Feb 202010:18 amRNSDirector Declaration
14th Feb 20207:00 amRNSNotice of trading update and preliminary results
23rd Jan 20204:06 pmRNSHolding(s) in Company
16th Jan 20201:08 pmRNSDirector Declaration
17th Dec 20197:00 amRNSTrading performance for first 9 months of FY 2020
16th Dec 201912:54 pmRNSHolding(s) in Company
3rd Dec 20194:37 pmRNSHolding(s) in Company
28th Nov 20199:01 amRNSHolding(s) in Company
28th Nov 20199:00 amRNSHolding(s) in Company
26th Nov 20194:12 pmRNSChange to date of trading update
19th Nov 20199:09 amRNSHolding(s) in Company
15th Nov 201912:15 pmRNSHolding(s) in Company
12th Nov 20195:30 pmRNSTrainline
12th Nov 20199:31 amRNSAnnouncement on Board of Directors
12th Nov 20197:00 amRNSResult of placing in Trainline plc
11th Nov 20194:49 pmRNSProposed Secondary Placing in Trainline plc
6th Nov 20192:48 pmRNSHolding(s) in Company
5th Nov 20197:00 amRNSTrainline Half-year Results
23rd Sep 20195:33 pmRNSHolding(s) in Company
20th Sep 20196:00 pmRNSTrainline
20th Sep 201911:49 amRNSAnnouncement on Board of Directors
20th Sep 20197:00 amRNSResult of placing in Trainline plc
19th Sep 20194:40 pmRNSProposed Secondary Placing in Trainline plc
12th Sep 20197:00 amRNSBoard Change - Chairman Transition
12th Sep 20197:00 amRNSH1 Trading Statement and Notice of H1 Results
2nd Aug 201911:29 amRNSPDMR Dealing Notification
31st Jul 20197:00 amRNSReduction of Capital
2nd Jul 20197:00 amRNSTrading Statement for first quarter FY2020
28th Jun 20194:48 pmRNSPDMR dealing notification
28th Jun 20194:47 pmRNSTotal Voting Rights
27th Jun 20197:00 amRNSStandard form for notification of major holdings
27th Jun 20197:00 amRNSStandard form for notification of major holdings
26th Jun 20193:51 pmRNSNotification of PDMR Transaction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.